NL7103889A - - Google Patents

Info

Publication number
NL7103889A
NL7103889A NL7103889A NL7103889A NL7103889A NL 7103889 A NL7103889 A NL 7103889A NL 7103889 A NL7103889 A NL 7103889A NL 7103889 A NL7103889 A NL 7103889A NL 7103889 A NL7103889 A NL 7103889A
Authority
NL
Netherlands
Application number
NL7103889A
Other versions
NL171269B (nl
NL171269C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7103889A publication Critical patent/NL7103889A/xx
Publication of NL171269B publication Critical patent/NL171269B/xx
Application granted granted Critical
Publication of NL171269C publication Critical patent/NL171269C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
NLAANVRAGE7103889,A 1970-03-23 1971-03-23 Werkwijze ter bereiding van een geneesmiddel, alsmede werkwijze ter bereiding van antimycotisch en fungitoxisch werkzame imidazol-1-yl-difenylmethaanderivaten. NL171269C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2013793A DE2013793C2 (de) 1970-03-23 1970-03-23 N-Methyl-imidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NL7103889A true NL7103889A (en:Method) 1971-09-27
NL171269B NL171269B (nl) 1982-10-01
NL171269C NL171269C (nl) 1983-03-01

Family

ID=5765958

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7103889,A NL171269C (nl) 1970-03-23 1971-03-23 Werkwijze ter bereiding van een geneesmiddel, alsmede werkwijze ter bereiding van antimycotisch en fungitoxisch werkzame imidazol-1-yl-difenylmethaanderivaten.

Country Status (21)

Country Link
US (1) US3787415A (en:Method)
JP (2) JPS5414107B1 (en:Method)
AT (1) AT301537B (en:Method)
BE (1) BE764700A (en:Method)
CA (1) CA971964A (en:Method)
CH (1) CH558802A (en:Method)
DE (1) DE2013793C2 (en:Method)
DK (1) DK143847C (en:Method)
ES (2) ES389495A1 (en:Method)
FI (1) FI55338C (en:Method)
FR (1) FR2085731B1 (en:Method)
GB (1) GB1288196A (en:Method)
HU (1) HU162527B (en:Method)
IE (1) IE35137B1 (en:Method)
IL (1) IL36272A0 (en:Method)
NL (1) NL171269C (en:Method)
NO (1) NO130536C (en:Method)
SE (1) SE369602B (en:Method)
SU (1) SU411688A3 (en:Method)
YU (1) YU34476B (en:Method)
ZA (1) ZA711268B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928348A (en) * 1970-03-23 1975-12-23 Bayer Ag N-methyl-imidazole derivatives and their production
US4062959A (en) * 1970-03-23 1977-12-13 Bayer Aktiengesellschaft N-methyl-imidazole derivatives for treating mycotic infections
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4384165A (en) * 1981-09-14 1983-05-17 Motorola, Inc. Radio frequency shield with force multiplier interconnection fingers for an electromagnetic gasket
US4755526A (en) * 1984-06-18 1988-07-05 Eli Lilly And Company Method of inhibiting aromatase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6915465D0 (pt) * 1969-03-07 1973-01-04 Bayer Ag Processo para preparar n-benzimidazois substituidos na posicao alfa por heterociclos penta-membrados com atividade antimicotica

Also Published As

Publication number Publication date
FR2085731A1 (en:Method) 1971-12-31
IE35137B1 (en) 1975-11-26
ES389495A1 (es) 1973-06-01
ZA711268B (en) 1971-11-24
NL171269B (nl) 1982-10-01
SE369602B (en:Method) 1974-09-09
CA971964A (en) 1975-07-29
JPS5414107B1 (en:Method) 1979-06-05
GB1288196A (en:Method) 1972-09-06
DK143847C (da) 1982-04-05
FI55338C (fi) 1979-07-10
IL36272A0 (en) 1971-04-28
NO130536C (en:Method) 1975-01-08
SU411688A3 (en:Method) 1974-01-15
JPS554754B1 (en:Method) 1980-01-31
AT301537B (de) 1972-09-11
CH558802A (de) 1975-02-14
US3787415A (en) 1974-01-22
YU34476B (en) 1979-09-10
FR2085731B1 (en:Method) 1974-09-27
HU162527B (en:Method) 1973-03-28
DE2013793A1 (de) 1971-10-28
IE35137L (en) 1971-09-23
DE2013793C2 (de) 1983-02-03
DK143847B (da) 1981-10-19
NO130536B (en:Method) 1974-09-23
ES391297A1 (es) 1973-07-01
BE764700A (fr) 1971-09-23
FI55338B (fi) 1979-03-30
NL171269C (nl) 1983-03-01
YU70171A (en) 1979-02-28

Similar Documents

Publication Publication Date Title
DK130997C (en:Method)
DK131555C (en:Method)
FI53043B (en:Method)
FI51488B (en:Method)
DK134827C (en:Method)
FR2077600A1 (en:Method)
FR2098777A5 (en:Method)
DK140842C (en:Method)
FI53180B (en:Method)
DK136256C (en:Method)
DK131079C (en:Method)
FR2085731B1 (en:Method)
JPS4915590B1 (en:Method)
FR2059343A5 (en:Method)
FR2065385A5 (en:Method)
FI49446B (en:Method)
FR2051038A5 (en:Method)
FR2059797A5 (en:Method)
DK139805C (en:Method)
DK135833C (en:Method)
DK139167C (en:Method)
FR2058950A5 (en:Method)
FR2059859A6 (en:Method)
AU465419B2 (en:Method)
FR2077033A5 (en:Method)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee